1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow Agomab Spain S.L.U.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of AGMB-447 in Participants With Idiopathic Pulmonary Fibrosis AGMB-447, Placebo - Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Not yet recruiting | Agomab Spain S.L.U. | 120 | 2026-11-30 | 2026-10-07 |
| NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease Ontunisertib, Placebo - Fibrostenotic Crohn's Disease | Phase 2 | Recruiting | Agomab Spain S.L.U. | 320 | 2026-10-30 | 2026-10-29 |
| STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease AGMB-129, Placebo - Fibrostenotic Crohn's Disease | Phase 2 | Completed | Agomab Spain S.L.U. | 103 | 2023-08-01 | 2026-07-09 |
Idiopathic Pulmonary Fibrosis (1)
United States (2) · Austria (1) · Canada (1) · Denmark (1) · Germany (1) · Italy (1) · Poland (1) · Serbia (1) · Spain (1) · United Kingdom (1)
Kay Tetzlaff, MD (1) · Philippe Wiesel, MD (1)